Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
279
-
Total 13F shares, excl. options
-
115M
-
Shares change
-
-14.4M
-
Total reported value, excl. options
-
$1.75B
-
Value change
-
-$256M
-
Put/Call ratio
-
1.3
-
Number of buys
-
108
-
Number of sells
-
-149
-
Price
-
$15.18
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2020
360 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2020.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 279 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 115M shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (20M shares), PAULSON & CO. INC. (13.2M shares), Adelphi Capital LLP (9.28M shares), VANGUARD GROUP INC (5.68M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.57M shares), MACQUARIE GROUP LTD (5.04M shares), RENAISSANCE TECHNOLOGIES LLC (3.76M shares), GMT CAPITAL CORP (3.57M shares), LMR Partners LLP (3.44M shares), and Mondrian Investment Partners LTD (3.43M shares).
This table shows the top 279 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.